GOLDFINCH BIOPHARMA
Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease. It is integrating breakthroughs in kidney genetics and biology to identify new therapeutic targets and advance first-in-class drug candidates to treat patients with kidney disease. Its Product Engine will industrialize the integration of genetics and kidney biology and confer a differentiated ability to identify, validate, and pursue novel therapeutic targets to treat progressive kidney disease. The company was founded in 2016 and is based in Cambridge, Massachusetts.
GOLDFINCH BIOPHARMA
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2015-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.goldfinchbio.com
Total Employee:
11+
Status:
Active
Contact:
(617)337-4200
Email Addresses:
[email protected]
Total Funding:
210 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Domain Not Resolving Wordpress Plugins
Similar Organizations
Anchiano Therapeutics
Anchiano is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Noctrix Health
Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.
Current Advisors List
Current Employees Featured
Founder
Investors List
BlackRock
BlackRock investment in Series B - Goldfinch Biopharma
Gilead Sciences
Gilead Sciences investment in Series B - Goldfinch Biopharma
Schroder Adveq
Schroder Adveq investment in Series B - Goldfinch Biopharma
Ally Bridge Group
Ally Bridge Group investment in Series B - Goldfinch Biopharma
Irving Investors
Irving Investors investment in Series B - Goldfinch Biopharma
Eventide
Eventide investment in Series B - Goldfinch Biopharma
Regent Capital
Regent Capital investment in Series B - Goldfinch Biopharma
Casdin Capital
Casdin Capital investment in Series B - Goldfinch Biopharma
Wellington Management
Wellington Management investment in Series B - Goldfinch Biopharma
Gilead Sciences
Gilead Sciences investment in Corporate Round - Goldfinch Biopharma
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-24 | Goldfinch Bio Announces Appointment of Edwin J. Tucker, M.D., as Chief Medical Officer |
Official Site Inspections
http://www.goldfinchbio.com
- Host name: 71.29.184.35.bc.googleusercontent.com
- IP address: 35.184.29.71
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Goldfinch Biopharma"
Goldfinch Bio has its wings clipped, shutting down …
Jan 27, 2023 Goldfinch Bio is closing down after seven years, wrapping up work on its kidney disease-focused pipeline.See details»
Goldfinch Bio - LinkedIn
Goldfinch Bio Biotechnology Research Cambridge, Massachusetts 3,862 followers We aspire to save kidneys and end dialysis by delivering disease …See details»
Goldfinch Biopharma - Crunchbase Company Profile
Goldfinch is a clinical-stage biotech company focused on discovering and …See details»
Goldfinch Bio Shutting Down - Global Genes
Jan 30, 2023 Goldfinch Bio, which raised $100 million in 2020 to advance development of experimental therapies for rare and metabolic kidney …See details»
Goldfinch Bio 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for …See details»
Goldfinch Bio Company Profile | Management and Employees List
Goldfinch Bio Profile and History Goldfinch Bio, Inc. is a clinical stage biotechnology company that leverages a genomics-based, precision medicine approach to discovering and developing …See details»
Goldfinch Bio, Inc. Company Profile | Cambridge, MA | Competitors ...
Find company research, competitor information, contact details & financial data for Goldfinch Bio, Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Goldfinch Bio - Craft
Goldfinch Bio (formerly known as Goldfinch Biopharma) is a company that develops precision medicines for patients with kidney disease. It offers KGA platform that identifies genetic and …See details»
What Happened To Goldfinch Bio & Why Did It Fail?
What Happened to Goldfinch Bio? The story of Goldfinch Bio is a compelling narrative of ambition, innovation, and eventual decline, marked by several critical phases: Initial Funding and …See details»
Goldfinch Bio | VentureRadar
Goldfinch Bio is a biotechnology company that is singularly focused on discovering and developing precision therapies for patients with kidney disease. Just as the goldfinch has long …See details»
Goldfinch Bio – Company Insights & Financial Strength – 2025
About Goldfinch Bio With a growing reputation in the Biotech landscape, Goldfinch Bio combines technology, talent, and timing to stay ahead of competitors, expanding its presence since 2016 …See details»
Karuna Therapeutics Announces Exclusive Global License …
Feb 2, 2023 Karuna to obtain exclusive global license to develop, manufacture, and commercialize multiple TRPC4/5 candidates, including lead clinical-stage candidate GFB-887 …See details»
Goldfinch Bio - Company Profile & Staff Directory | ContactOut
With our sole focus on kidney diseases, we aspire to be the world’s leading precision medicine kidney company. There are few therapeutic options that target the underlying cause of …See details»
Goldfinch Biopharma Company Profile | Cambridge, MA
Find company research, competitor information, contact details & financial data for Goldfinch Biopharma of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Goldfinch Bio - VentureRadar
Goldfinch Bio is a biotechnology company that is singularly focused on discovering and developing precision therapies for patients with kidney disease. Just as the goldfinch has long …See details»
Goldfinch Bio Strengthens Leadership Team with ... - Business Wire
Dec 6, 2021 Goldfinch Bio, Inc. is a clinical stage biotechnology company focused on delivering disease-modifying precision medicines that bring hope and renewed quality of life to people …See details»
Goldfinch Bio (USA) Funding: $210M - medicalstartups.org
Jun 6, 2025 USA | Funding: $210M (+) Website: https://www.goldfinchbio.com Goldfinch is singularly focused on discovering and developing precision therapies for patients with kidney …See details»
Goldfinch Bio - Medhealth Outlook
One such provider is Goldfinch Bio—a precision medicine kidney company focused on its mission of delivering disease-modifying precision medicines that bring hope and renewed quality of life …See details»
Goldfinch Bio - VentureRadar
"Goldfinch Bio is a biotechnology company that is singularly focused on discovering and developing precision therapies for patients with kidney disease. Just as the goldfinch has long …See details»
Goldfinch Biopharma - Profiles & Contacts - Crunchbase
Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease.See details»